Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature.

Our results confirm the emerging importance of molecular tumor profiling for the successful management of cancer, and the potential of BRAF-targeted therapy in the treatment of rare solid tumors with poor prognosis and no clinical benefit from systemic therapies with.